Trademark: 87736062
Word
EPI X
Status
Dead
Status Code
605
Status Date
Monday, May 6, 2019
Serial Number
87736062
Mark Type
4000
Filing Date
Wednesday, December 27, 2017
Published for Opposition
Tuesday, January 8, 2019
Abandoned Date
Monday, May 6, 2019

Trademark Owner History
Cellink AB - Owner At Publication

Classifications
1 Biologically compatible polymers, namely, hydrogels used to manufacture polymeric networks used in the manufacture of engineered living tissue for medical, scientific and non-scientific purposes; Media for cell culture for use in the biotechnological industry; Media for cell culture for use in non-medical research laboratories; Biological preparation for use in cell cultures other than for medical or veterinary use; Engineered biological tissues and tissue arrays, namely, human and animal organ, connective, epithelial, muscular, and nervous tissues and tissue arrays, for use in scientific and medical research; Biologically compatible materials, namely, hydrogels used to create polymeric networks used in the manufacture of living tissue; Proteins in raw material form for scientific and medical research
5 Pharmaceutical preparations for use in the field of 3D bio-printing of tissues and organs; Preparations based on cellulous nano-fibrils for use in the 3D bio-printing of tissues and organs; Tissue-regenerative pharmaceutical preparations; Cells for medical use; Human allograft tissue; Living cells for medical use; Implants of living tissues for guided tissue regeneration; Implants comprising living tissue; Implantable materials of living tissue for use in guided tissue regeneration; Skin grafts; Surgical implants comprised of living tissues; Surgical implants of living tissues grown from stem cells; Transdermal patches for use to create skin for prosthetic limbs and for skin grafts; Living tissues for transplant; Engineered biological tissues and organs, namely, human and animal cardiovascular, pulmonary, digestive, hepatobiliary, urological, renal, endocrine, connective, epithelial, muscular, and nervous tissue and organs, for medical purposes; Biological molecules to assist in the development of tissue; Haemostatic gel matrix preparations for treating wounds; Natural biomaterials for augmentation of bone, blood and tissue for medical purposes; Pharmaceutical products for tissue regeneration, for tissue repair, for tissue treatment, whether relating to human or animal tissue; Pharmaceutical preparations for the treatment of bone diseases, for cartilaginous diseases, for vascular diseases, for neuronal degeneration, for degeneration of tendons and ligaments, for retinal degeneration, for renal degeneration, degeneration of soft tissue, for diseases with abnormal cell proliferation; Natural biomaterials for bone filling; Natural biomaterials for filling cartilage; Biological tissue cultures for medical use; Biological tissue cultures for medical purposes; Biological tissue grafts; Biological bone and skin tissues impregnated with lines of oxygen for tissue engineering applications to increase cell survival in tissue intended for subsequent implantation; Gene therapy products, namely, genetically engineered tissues for transplant purposes; Implantable scaffolds comprising living tissue for maintaining tissue contour; Implants comprising living tissue; Natural biomaterials for augmentation of bone and tissue for medical purposes

Trademark Events
May 6, 2019
Abandonment Notice E-Mailed - After Publication
May 6, 2019
Abandonment - After Publication
May 2, 2019
Teas Express Abandonment Received
Feb 1, 2019
Extension Of Time To Oppose Received
Jan 8, 2019
Official Gazette Publication Confirmation E-Mailed
Jan 8, 2019
Published For Opposition
Dec 19, 2018
Notification Of Notice Of Publication E-Mailed
Dec 2, 2018
Approved For Pub - Principal Register
Nov 13, 2018
Teas/Email Correspondence Entered
Nov 13, 2018
Correspondence Received In Law Office
Nov 9, 2018
Teas Response To Suspension Inquiry Received
Nov 5, 2018
Lie Checked Susp - To Atty For Action
Nov 1, 2018
Assigned To Lie
Apr 14, 2018
Notification Of Letter Of Suspension E-Mailed
Apr 14, 2018
Letter Of Suspension E-Mailed
Apr 14, 2018
Suspension Letter Written
Apr 6, 2018
Assigned To Examiner
Jan 12, 2018
New Application Office Supplied Data Entered In Tram
Dec 30, 2017
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24